- Erratum
- Open access
- Published:
Erratum to: Heregulin-1ß and HER3 in hepatocellular carcinoma: status and regulation by insulin
Journal of Experimental & Clinical Cancer Research volume 35, Article number: 154 (2016)
The Original Article was published on 11 August 2016
Erratum description
In the original publication of this article [1], one of the co-authors’ names contained a spelling error. ‘Fatiha Meratbene’ should therefore have been listed as ‘Fatiha Merabtene’. The original publication has now been modified as well to reflect these changes.
References
Buta C, et al. Heregulin-1ß and HER3 in hepatocellular carcinoma: status and regulation by insulin. J Exp Clin Cancer Res. 2016;35:126. doi:10.1186/s13046-016-0402-3.
Author information
Authors and Affiliations
Corresponding author
Additional information
The online version of the original article can be found under doi:10.1186/s13046-016-0402-3.
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
About this article
Cite this article
Buta, C., Benabou, E., Lequoy, M. et al. Erratum to: Heregulin-1ß and HER3 in hepatocellular carcinoma: status and regulation by insulin. J Exp Clin Cancer Res 35, 154 (2016). https://doi.org/10.1186/s13046-016-0438-4
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s13046-016-0438-4